The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...

At the just‑concluded CES show in Las Vegas, tech fans and homeowners alike have reason to be excited about what’s coming to ...